首页> 外文期刊>Nephron >Renal CCAAT/enhancer-binding proteins in experimental diabetes mellitus.
【24h】

Renal CCAAT/enhancer-binding proteins in experimental diabetes mellitus.

机译:实验性糖尿病中的肾脏CCAAT /增强子结合蛋白。

获取原文
获取原文并翻译 | 示例
           

摘要

There is evidence that mediators of inflammation including components of the cytokine system are present in human and experimental diabetic kidney disease. CCAAT/enhancer-binding proteins (C/EBPs) represent a family of cytokine-inducible transcription factors. C/EBPs themselves regulate cytokine expression and also the expression of acute-phase reactants and connective tissue proteins. At least three C/EBP isoforms (alpha, beta, delta) are known. Upon stimulation with cytokines or bacterial lipopolysaccharide, the expression of the alpha isoform typically decreases, and the expression of the beta and/or delta isoforms increases. In view of the fact that components of the inflammatory response are present in diabetic kidney disease, there is a potential that the expression and activity of renal C/EBPs are altered in the diabetic state. In this study we sought to examine the status of C/EBP proteins in kidneys of rats with streptozotocin-induced diabetes mellitus. Diabetes was induced in 5 male Sprague-Dawley rats. Eight weight-matched non-diabetic rats were used as controls. Animals were sacrificed after 4 weeks, and the whole kidney nuclear protein was extracted. An electrophoretic mobility shift assay showed that DNA-binding activity was present in all five kidney nuclear extracts of the diabetic animals, but in only 2 out of 8 control samples (p < 0.05). A supershift assay showed that the DNA-bound protein complex consisted mainly of the C/EBPbeta isoform. Western analysis showed an increase of the C/EBPbeta protein in renal nuclear extracts of the diabetic animals compared to controls (p < 0.05). There was a decrease of the C/EBPalpha protein in the kidney nuclear extracts of the diabetic animals compared to controls (p < 0.05). We conclude that renal C/EBP dynamics are altered in experimental diabetes mellitus and that the patterns of C/EBP changes resemble those observed after cytokine or lipopolysaccharide stimulation.
机译:有证据表明,人类和实验性糖尿病肾脏疾病中都存在炎症介质,包括细胞因子系统的成分。 CCAAT /增强子结合蛋白(C / EBP)代表细胞因子诱导型转录因子家族。 C / EBP本身调节细胞因子的表达,还调节急性期反应物和结缔组织蛋白的表达。已知至少三个C / EBP同工型(α,β,δ)。在用细胞因子或细菌脂多糖刺激后,α同工型的表达通常降低,而β和/或δ同工型的表达增加。考虑到在糖尿病性肾脏疾病中存在炎症反应的成分,在糖尿病状态下肾脏C / EBP的表达和活性可能会改变。在这项研究中,我们试图检查链脲佐菌素诱导的糖尿病大鼠肾脏中C / EBP蛋白的状态。在5只雄性Sprague-Dawley大鼠中诱发糖尿病。将八只体重匹配的非糖尿病大鼠用作对照。 4周后处死动物,并提取整个肾核蛋白。电泳迁移率变动分析表明,糖尿病动物的所有五种肾核提取物中均存在DNA结合活性,但在8个对照样品中只有2个存在(p <0.05)。超位移分析表明,DNA结合蛋白复合物主要由C / EBPbeta同工型组成。 Western分析显示,与对照组相比,糖尿病动物肾脏核提取物中C / EBPbeta蛋白增加(p <0.05)。与对照组相比,糖尿病动物肾脏核提取物中的C / EBPalpha蛋白降低(p <0.05)。我们得出的结论是,实验性糖尿病患者的肾脏C / EBP动力学改变,并且C / EBP的变化模式与细胞因子或脂多糖刺激后观察到的相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号